Hasan KM, Elmeshhadany AY, Shabila NP. Evaluation of Ruxolitinib versus Best Available Therapy in Treating Primary Myelofibrosis. Sultan Qaboos Univ Med J [Internet]. 2022Aug.25 [cited 2024Apr.25];22(3):393-9. Available from: https://journals.squ.edu.om/index.php/squmj/article/view/4522